Sangamo Therapeutics, Inc
SGMOQ- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001001233
No open-market purchases or sales by Sangamo Therapeutics, Inc insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $29.0K in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Sangamo Therapeutics, Inc as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 114
- −7 vs. Q1 2025
- Shares held
- 73.2M
- +20.7M (+39.3%) vs. Q1 2025
- Total value
- $39.6M
- +$5.15M (+14.9%) vs. Q1 2025
- New holders
- 17
- 30 more added
- Sold out
- 24
- 32 more reduced
1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SGMOQ on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 6 | $29.0K |
| Q1 2026 | 112 | $26.0M |
| Q4 2025 | 105 | $26.2M |
| Q3 2025 | 112 | $42.1M |
| Q2 2025 | 114 | $39.6M |
| Q1 2025 | 122 | $34.5M |
| Q4 2024 | 128 | $62.9M |
| Q3 2024 | 103 | $48.6M |
| Q2 2024 | 129 | $31.1M |
| Q1 2024 | 131 | $68.2M |
| Q4 2023 | 130 | $47.2M |
| Q3 2023 | 135 | $61.3M |
| Q2 2023 | 152 | $137.4M |
| Q1 2023 | 180 | $197.6M |
| Q4 2022 | 182 | $326.0M |
| Q3 2022 | 197 | $477.2M |
| Q2 2022 | 188 | $371.1M |
| Q1 2022 | 195 | $459.6M |
| Q4 2021 | 193 | $577.0M |
| Q3 2021 | 193 | $679.3M |
| Q2 2021 | 197 | $912.0M |
| Q1 2021 | 203 | $994.7M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Sangamo Therapeutics, Inc; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| State Street Corp | 836,452 | $452.8K | 0.00% | −286,492−25.5% | Reduced |
| Jacobs Levy Equity Management, Inc | 846,533 | $458.2K | 0.00% | −451,252−34.8% | Reduced |
| Two Sigma Investments, LP | 877,079 | $474.8K | 0.00% | +90,334+11.5% | Added |
| Two Sigma Advisers, LP | 1,206,734 | $653.2K | 0.00% | +307,479+34.2% | Added |
| UBS Group AG | 1,249,009 | $675.7K | 0.00% | +638,043+104.4% | Added |
| Ikarian Capital, LLC | 1,260,179 | $682.1K | 0.23% | −600,000−32.3% | Reduced |
| Charles Schwab Investment Management Inc | 1,281,799 | $693.8K | 0.00% | +183,965+16.8% | Added |
| Gsa Capital Partners LLP | 2,245,449 | $1.22M | 0.09% | +1,279,247+132.4% | Added |
| Geode Capital Management, LLC | 2,332,279 | $1.26M | 0.00% | +48,829+2.1% | Added |
| BlackRock, Inc. | 4,808,708 | $2.60M | 0.00% | −636,310−11.7% | Reduced |
| Renaissance Technologies LLC | 6,839,434 | $3.70M | 0.00% | +3,671,327+115.9% | Added |
| Wasatch Advisors Inc | 8,084,419 | $4.38M | 0.02% | +1,215,653+17.7% | Added |
| Vanguard Group Inc | 9,374,728 | $5.07M | 0.00% | 00.0% | Unchanged |
| Yorkville Advisors Global, LP | 22,000,000 | $11.9M | 6.09% | +22,000,000 | New |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −1,998,043−100.0% | Sold out |
| Opaleye Management Inc. | 0 | $0 | 0.00% | −1,055,000−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −651,906−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −431,766−100.0% | Sold out |
| Assenagon Asset Management S.A. | 0 | $0 | 0.00% | −293,949−100.0% | Sold out |
| Omers Administration Corp | 0 | $0 | 0.00% | −207,800−100.0% | Sold out |
| Jain Global LLC | 0 | $0 | 0.00% | −146,194−100.0% | Sold out |
| Mitsubishi UFJ Kokusai Asset Management Co., Ltd. | 0 | $0 | 0.00% | −135,382−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −80,584−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −72,077−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −66,018−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −55,700−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −54,385−100.0% | Sold out |
| Capstone Investment Advisors, LLC | 0 | $0 | 0.00% | −45,347−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −42,370−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −34,382−100.0% | Sold out |
| Wolverine Trading, LLC | 0 | $0 | 0.00% | −25,486−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −31,425−100.0% | Sold out |
| Shelton Wealth Management, LLC | 0 | $0 | 0.00% | −28,000−100.0% | Sold out |
| LaSalle St. Investment Advisors, LLC | 0 | $0 | 0.00% | −19,200−100.0% | Sold out |
| TradeLink Capital LLC | 0 | $0 | 0.00% | −16,200−100.0% | Sold out |
| CTC Alternative Strategies, Ltd. | 0 | $0 | 0.00% | −15,800−100.0% | Sold out |
| Capula Management Ltd | 0 | $0 | 0.00% | −15,690−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −2,668−100.0% | Sold out |
| Sandy Spring Bank | – | – | – | – | Not filed |